Disparities in risk stratification guidance for patients taking immunosuppressive drugs during the COVID-19 pandemic – points to ponder

Thng ZX De Smet MD Lee CS , et al. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol 2021; 105: 306–10.

British Society of Gastroenterology. BSG COVID-19 Guidance on IBD patient risk groups. London: British Society of Gastroenterology, https://www.bsg.org.uk/covid-19-advice/bsg-advice-on-ibd-patient-risk-groups/ (2021, accessed 6 November 2021).

British Society of Rheumatology. COVID-19 – Identifying patients for shielding in England. London: British Society of Rheumatology, https://www.rheumatology.org.uk/Portals/0/Documents/COVID-19/Rheumatology_advice_coronavirus_immunosuppressed_patients_220320.pdf?ver=2020-03-24-171132-407 (2021, accessed 6 November 2021).

British Association of Dermatology. Dermatology advice regarding medication acting on the immune system, https://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=6946 (2020, accessed 6 November 2021).

Gianfrancesco M Hyrich KL Al-Adely S , et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheumatic Dis 2020; 79: 859.